Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo

BACKGROUND: Duloxetine has been approved in the United States, European Union and some Asian countries for the treatment of diabetic peripheral neuropathic pain (DPNP). We assessed the efficacy and safety of duloxetine (60 mg once daily) compared with placebo in Chinese patients suffering from DPNP....

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Y, Guo, X, Han, P, Li, Q, Yang, G, Qu, S, Yue, L, Wang, C-N, Skljarevski, V, Dueñas, H, Raskin, J, Gu, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Endocrinology and Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682474/
https://www.ncbi.nlm.nih.gov/pubmed/25939897
http://dx.doi.org/10.1111/ijcp.12641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682474/
https://www.ncbi.nlm.nih.gov/pubmed/25939897
http://dx.doi.org/10.1111/ijcp.12641

Ejemplares similares